Invus Financial Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $24.6M | Hold |
1,612,077
| – | – | 27.51% | 2 |
|
|
2024
Q1 | $30.4M | Hold |
1,612,077
| – | – | 24.2% | 2 |
|
|
2023
Q4 | $30.8M | Hold |
1,612,077
| – | – | 24.1% | 2 |
|
|
2023
Q3 | $28.9M | Hold |
1,612,077
| – | – | 18.14% | 3 |
|
|
2023
Q2 | $32.7M | Hold |
1,612,077
| – | – | 17.51% | 3 |
|
|
2023
Q1 | $29.4M | Hold |
1,612,077
| – | – | 19.15% | 2 |
|
|
2022
Q4 | $33.3M | Hold |
1,612,077
| – | – | 17.74% | 2 |
|
|
2022
Q3 | $42.2M | Hold |
1,612,077
| – | – | 23.15% | 2 |
|
|
2022
Q2 | $40.9M | Hold |
1,612,077
| – | – | 24.66% | 1 |
|
|
2022
Q1 | $50.9M | Hold |
1,612,077
| – | – | 22.64% | 2 |
|
|
2021
Q4 | $65.2M | Sell |
1,612,077
-230,000
| -12% | -$9.31M | 19.83% | 2 |
|
|
2021
Q3 | $64.2M | Hold |
1,842,077
| – | – | 17.21% | 3 |
|
|
2021
Q2 | $50.6M | Hold |
1,842,077
| – | – | 10.08% | 4 |
|
|
2021
Q1 | $51.7M | Hold |
1,842,077
| – | – | 11.86% | 2 |
|
|
2020
Q4 | $47.8M | Hold |
1,842,077
| – | – | 19.99% | 3 |
|
|
2020
Q3 | $31.6M | Hold |
1,842,077
| – | – | 15.19% | 4 |
|
|
2020
Q2 | $45.6M | Hold |
1,842,077
| – | – | 16.47% | 3 |
|
|
2020
Q1 | $25.6M | Hold |
1,842,077
| – | – | 12.55% | 4 |
|
|
2019
Q4 | $18.6M | Buy |
+1,842,077
| New | +$18.6M | 9.44% | 4 |
|